CompletedNot Applicable

Case Management in HCV Infected PWID

Belgium441 participantsStarted 2016-07

Plain-language summary

To study the impact of case management on the outcome of the care of chronic hepatitis C in people who inject drugs (PWID). By creating the function of case manager, the investigators will target all the barriers to care of the HCV care continuum. Partial objectives are to measure the impact of case management on the uptake for screening, the uptake and outcome of treatment, and the rate of reinfection.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria * ≥ 18 years of age * History of injection drug use with substitution program * Written informed consent obtained Exclusion criteria * Possible acute HCV infection within the previous 6 months defined by one of the following: acute hepatitis symptoms, ALT ≥ 10x ULN, negative or unknown HCV antibody status

What they're measuring

Uptake for screening (%)

Timeframe: screening

Uptake for treatment assessment (%)

Timeframe: day 1

Uptake for treatment (%)

Timeframe: day 1

Compliance to therapy (%)

Timeframe: up to three years

Rate of sustained viral response (SVR) (%)

Timeframe: up to three years

Rate of reinfection (%)

Timeframe: up to three years

Trial details

NCT IDNCT03106194

SponsorHasselt University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-11-30

View on ClinicalTrials.gov More Drug Abuse, Intravenous trials